IL1RL2 and Alzheimer disease: Keratinocyte-released IL-36 cytokines increase IL-4-mediated immunoglobulin (Ig)E production in B cells in AD, and treatment with an IL-36R-blocking antibody decreases IgE production and alleviates the disease phenotype46.